NCT03343197 2026-02-17Study of AG-120 and AG-881 in Subjects With Low Grade GliomaServierPhase 1 Completed49 enrolled
NCT04176393 2023-02-13A China Bridging Study of Ivosidenib in r/r AML Subjects With an IDH1 MutationCStone PharmaceuticalsPhase 1 Completed30 enrolled